检索历史清除

首页> Journal of medicinal chemistry> Correction to Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model.

Correction to Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model.

导出原文传递

翻译打印收藏纠错

作者： Yueshan,Li ; Yu,Xiong ; Guo,Zhang ; Liting,Zhang ; Wei,Yang ; Jiao,Yang ; Luyi,Huang ; Zeen,Qiao ; Zhuang,Miao ; Guifeng,Lin ; Qiu,Sun ; Ting,Niu ; Lijuan,Chen ; Dawen,Niu ; Linli,Li ; Shengyong,Yang

DOI 10.1021/acs.jmedchem.9b00368

PMID 30843694

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交